T2DM is characterized as a metabolic disorder with defects in both insulin secretion and insulin action, and is also characterized by the presence of fibrillar amyloid deposits in the pancreatic islet of Langerhans, suggesting that T2DM is classified to protein-misfolding disease. The gene discussed is INS; the disease is proteostasis deficiencies.